SE408301B - Sett att framtella 1-substituerade pyrazoloner -(5) - Google Patents
Sett att framtella 1-substituerade pyrazoloner -(5)Info
- Publication number
- SE408301B SE408301B SE7405078A SE7405078A SE408301B SE 408301 B SE408301 B SE 408301B SE 7405078 A SE7405078 A SE 7405078A SE 7405078 A SE7405078 A SE 7405078A SE 408301 B SE408301 B SE 408301B
- Authority
- SE
- Sweden
- Prior art keywords
- methyl
- group
- pyrazolone
- carbon atoms
- acid
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
- C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
- C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D231/14—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D231/18—One oxygen or sulfur atom
- C07D231/20—One oxygen atom attached in position 3 or 5
- C07D231/22—One oxygen atom attached in position 3 or 5 with aryl radicals attached to ring nitrogen atoms
- C07D231/24—One oxygen atom attached in position 3 or 5 with aryl radicals attached to ring nitrogen atoms having sulfone or sulfonic acid radicals in the molecule
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/10—Antioedematous agents; Diuretics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
- C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
- C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D231/14—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D231/18—One oxygen or sulfur atom
- C07D231/20—One oxygen atom attached in position 3 or 5
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
- C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
- C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D231/14—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D231/44—Oxygen and nitrogen or sulfur and nitrogen atoms
- C07D231/52—Oxygen atom in position 3 and nitrogen atom in position 5, or vice versa
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Hematology (AREA)
- Diabetes (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
- Catalysts (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE2319280A DE2319280A1 (de) | 1973-04-17 | 1973-04-17 | 1-substituierte pyrazolone-(5), verfahren zu ihrer herstellung sowie ihre verwendung als arzneimittel |
DE2363139A DE2363139A1 (de) | 1973-12-19 | 1973-12-19 | 1-substituierte pyrazolone-(5), verfahren zu ihrer herstellung sowie ihre verwendung als arzneimittel |
Publications (1)
Publication Number | Publication Date |
---|---|
SE408301B true SE408301B (sv) | 1979-06-05 |
Family
ID=25764996
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SE7405078A SE408301B (sv) | 1973-04-17 | 1974-04-16 | Sett att framtella 1-substituerade pyrazoloner -(5) |
Country Status (27)
Country | Link |
---|---|
US (1) | US3957814A (it) |
JP (1) | JPS5314071B2 (it) |
AR (5) | AR207444A1 (it) |
AT (1) | AT337176B (it) |
BG (5) | BG21405A3 (it) |
CA (1) | CA1034953A (it) |
CH (5) | CH603592A5 (it) |
DD (1) | DD113757A5 (it) |
DK (1) | DK136066C (it) |
EG (1) | EG11157A (it) |
ES (3) | ES425373A1 (it) |
FI (1) | FI57587C (it) |
FR (1) | FR2226172B1 (it) |
GB (1) | GB1429141A (it) |
HK (1) | HK70276A (it) |
HU (1) | HU168590B (it) |
IE (1) | IE39212B1 (it) |
IL (1) | IL44626A (it) |
LU (1) | LU69872A1 (it) |
NL (1) | NL177917C (it) |
NO (1) | NO138530C (it) |
PH (1) | PH14829A (it) |
PL (1) | PL96883B1 (it) |
RO (2) | RO69740A (it) |
SE (1) | SE408301B (it) |
SU (2) | SU539525A3 (it) |
YU (1) | YU104874A (it) |
Families Citing this family (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4056533A (en) * | 1973-04-17 | 1977-11-01 | Bayer Aktiengesellschaft | Pyrazol-5-ones |
DE2526467A1 (de) * | 1975-06-13 | 1976-12-30 | Bayer Ag | 4-substituierte pyrazolderivate, verfahren zu ihrer herstellung sowie ihre verwendung als arzneimittel |
DE3306366A1 (de) * | 1983-02-24 | 1984-08-30 | Bayer Ag, 5090 Leverkusen | Muzolimin enthaltende arzneimittel, deren verwendung und verfahren zu deren herstellung |
US4663327A (en) * | 1984-05-23 | 1987-05-05 | Bayer Aktiengesellschaft | 1-heteroaryl-4-aryl-pyrazolin-5-ones |
JPH0730031B2 (ja) * | 1986-04-02 | 1995-04-05 | 日産化学工業株式会社 | 2―ピラゾリン―5―オン類の製造法 |
DE3738963A1 (de) * | 1987-11-17 | 1989-05-24 | Bayer Ag | 3-aminopyrazolin-5-one |
GB8912861D0 (en) * | 1989-06-05 | 1989-07-26 | Sherritt Gordon Ltd | Purification of elemental sulphur |
US5711929A (en) * | 1989-05-06 | 1998-01-27 | 698638 Alberta Ltd. | Purification of elemental sulphur |
JPH079410Y2 (ja) * | 1989-05-08 | 1995-03-06 | 株式会社アンレット | 炭酸ガスレーザー光線発振器用ルーツブロワー |
US5399565A (en) * | 1990-07-17 | 1995-03-21 | Eli Lilly And Company | Pyrazolidinone CCK and gastrin antagonists and pharmaceutical formulations therof |
US5300514A (en) * | 1990-07-17 | 1994-04-05 | Eli Lilly And Company | Pyrazolidinone CCK and gastrin antagonists and pharmaceutical formulations thereof |
ATE180475T1 (de) * | 1990-09-21 | 1999-06-15 | Rohm & Haas | Dihydropyridazinone und pyridazinone als fungizide |
CN1038249C (zh) * | 1991-08-28 | 1998-05-06 | 罗姆和哈斯公司 | 含有二氢哒嗪酮及其相关化合物的杀菌组合物 |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US2376380A (en) * | 1945-05-22 | Preparation of amino pyrazolones | ||
GB636988A (en) * | 1947-12-24 | 1950-05-10 | Gevaert Photo Producten Naamlo | Improvements in and relating to the production of colour photographic images |
US2511231A (en) * | 1949-03-26 | 1950-06-13 | Eastman Kodak Co | 1-cyanophenyl-3-acylamino-5-pyrazolone couplers for color photography |
US2600788A (en) * | 1949-06-07 | 1952-06-17 | Eastman Kodak Co | Halogen-substituted pyrazolone couplers for color photography |
US2672417A (en) * | 1949-12-31 | 1954-03-16 | Gevaert Photo Prod Nv | Production of color photographic images |
NL121416C (it) * | 1961-05-31 |
-
1974
- 1974-01-01 AR AR253331A patent/AR207444A1/es active
- 1974-03-29 FR FR7411495A patent/FR2226172B1/fr not_active Expired
- 1974-04-09 HU HUBA3058A patent/HU168590B/hu unknown
- 1974-04-11 FI FI1105/74A patent/FI57587C/fi active
- 1974-04-12 IL IL44626A patent/IL44626A/xx unknown
- 1974-04-12 BG BG027980A patent/BG21405A3/xx unknown
- 1974-04-12 BG BG026395A patent/BG21217A3/xx unknown
- 1974-04-12 BG BG027979A patent/BG22821A3/xx unknown
- 1974-04-12 BG BG027977A patent/BG21857A3/xx unknown
- 1974-04-12 BG BG027978A patent/BG21218A3/xx unknown
- 1974-04-15 RO RO7485201A patent/RO69740A/ro unknown
- 1974-04-15 RO RO7400078420A patent/RO63749A/ro unknown
- 1974-04-15 DD DD177913A patent/DD113757A5/xx unknown
- 1974-04-15 US US05/461,282 patent/US3957814A/en not_active Expired - Lifetime
- 1974-04-15 YU YU01048/74A patent/YU104874A/xx unknown
- 1974-04-15 JP JP4111274A patent/JPS5314071B2/ja not_active Expired
- 1974-04-15 PH PH15730A patent/PH14829A/en unknown
- 1974-04-16 AT AT313274A patent/AT337176B/de not_active IP Right Cessation
- 1974-04-16 DK DK208074A patent/DK136066C/da not_active IP Right Cessation
- 1974-04-16 PL PL1974170378A patent/PL96883B1/pl unknown
- 1974-04-16 CH CH524274A patent/CH603592A5/xx not_active IP Right Cessation
- 1974-04-16 CH CH156677A patent/CH605797A5/xx not_active IP Right Cessation
- 1974-04-16 EG EG119/74A patent/EG11157A/xx active
- 1974-04-16 ES ES425373A patent/ES425373A1/es not_active Expired
- 1974-04-16 NO NO741365A patent/NO138530C/no unknown
- 1974-04-16 LU LU69872A patent/LU69872A1/xx unknown
- 1974-04-16 SE SE7405078A patent/SE408301B/sv not_active IP Right Cessation
- 1974-04-16 CH CH156377A patent/CH596172A5/xx not_active IP Right Cessation
- 1974-04-16 CH CH156577A patent/CH605800A5/xx not_active IP Right Cessation
- 1974-04-16 GB GB1650774A patent/GB1429141A/en not_active Expired
- 1974-04-16 NL NLAANVRAGE7405115,A patent/NL177917C/xx not_active IP Right Cessation
- 1974-04-16 CH CH156477A patent/CH605801A5/xx not_active IP Right Cessation
- 1974-04-17 CA CA197,660A patent/CA1034953A/en not_active Expired
- 1974-04-17 IE IE798/74A patent/IE39212B1/xx unknown
-
1975
- 1975-01-01 AR AR258506A patent/AR208192A1/es active
- 1975-01-01 AR AR258508A patent/AR205272A1/es active
- 1975-01-01 AR AR258507A patent/AR205271A1/es active
- 1975-03-19 SU SU2115103A patent/SU539525A3/ru active
- 1975-03-19 SU SU2114308A patent/SU541430A3/ru active
- 1975-04-25 AR AR258505A patent/AR204951A1/es active
-
1976
- 1976-04-15 ES ES447063A patent/ES447063A1/es not_active Expired
- 1976-04-15 ES ES447064A patent/ES447064A1/es not_active Expired
- 1976-11-11 HK HK702/76*UA patent/HK70276A/xx unknown
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP1713475B1 (en) | 1,3,5-trisubstituted 4,5-dihydro-1h-pyrazole derivatives having cb1-antagonistic activity | |
JP4495257B2 (ja) | Nos抑制剤としてのn−複素環誘導体 | |
EP1725536B1 (en) | Imidazoline derivatives having cb1-antagonistic activity | |
AU777735B2 (en) | Bradykinin B1 receptor antagonists | |
SE408301B (sv) | Sett att framtella 1-substituerade pyrazoloner -(5) | |
JPH07324076A (ja) | 新規なピラゾール−3−カルボキサミド誘導体、これらを製造するための方法及びこれらが存在する薬学的組成物 | |
US7745476B2 (en) | 1,3,5-trisubstituted 4,5-dihydro-1H-pyrazole derivatives having CB1-antagonistic activity | |
KR19990063989A (ko) | 염증 치료용의 1,3,5-삼치환된 피라졸 화합물 | |
CA2408408C (en) | Modulators of tnf- alpha signaling | |
HU187478B (en) | Process for preparing new imidazolyl-phenyl-amidines and pharmaceutical compositions containing thereof | |
US4288446A (en) | Pyrazol-5-ones | |
DE1946370B2 (de) | Substituierte Pyrazol-4-essigsauren, Verfahren zu ihrer Herstellung und sie enthaltende Arzneimittel | |
FR2537584A1 (fr) | Pyrazoloquinoleines substituees particulieres, procede pour leur preparation, preparations pharmaceutiques contenant ces composes et leur application therapeutique | |
PL93398B1 (it) | ||
US3250761A (en) | New sulfonamides | |
US3962453A (en) | Novel pyrazolyloxyacetic acid derivatives and process for the preparation thereof | |
CA1048513A (en) | Pyrazol-5-ones | |
HUT52038A (en) | Process for producing alpha-cyano-beta-oxo-propion-amides | |
US3365447A (en) | 2, 5-dihydro-4-hydroxy-2-oxothiophens | |
US4207317A (en) | 1-Aryl-4-carbamoyl-pyrazolin-5-ones | |
US4000294A (en) | Pyrazol-5-ones | |
US4038410A (en) | Nitroimidazole derivatives and process for the preparation thereof | |
RU2026293C1 (ru) | Способ получения производного имидазола | |
WO2000018741A2 (en) | Pyrazole compounds as cox-2 inhibitors | |
DE2526467A1 (de) | 4-substituierte pyrazolderivate, verfahren zu ihrer herstellung sowie ihre verwendung als arzneimittel |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
NUG | Patent has lapsed |
Ref document number: 7405078-2 Effective date: 19900411 Format of ref document f/p: F |